Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
about
Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate.Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis
P2860
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@en
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@nl
type
label
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@en
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@nl
prefLabel
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@en
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
@nl
P2093
P2860
P50
P1476
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins
@en
P2093
Jawed Fareed
Nigel S Key
Wenfang Dou
Xing Zhang
P2860
P356
10.1126/SCITRANSLMED.AAN5954
P407
P50
P577
2017-09-01T00:00:00Z